Arizona State University

Harvard College

Dana-farber-cancer Institute Inc.

The United States of America, As Represented by the Secretary, Department of Health and Human Services

The Brigham and Women's Hospital, Inc.

Arizona Board of Regents, a Body Corporate

National Institutes of Health

Garrick Wallstrom

Joshua LaBaer

Karen Anderson

Jin Park

Niroshan Ramachandran

Sahar Sibani

Benjamin Katchman

Daniel Cramer

Jie Wang

Vel Murugan

Mitch Magee

Kristin Gillis

Jonine Figueroa

Ji Qiu

Ji Qui

Karen Sue Anderson

Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.

Autoantibody biomarkers for the early detection of ovarian cancer

Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).

Plasma autoantibody biomarkers for basal like breast cancer

The present invention provides reagents and methods for breast cancer detection.

Biomarkers for the early detection of breast cancer

Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.

Radiation biodosimetry systems

Growing community of inventors

Mesa, AZ, United States of America

Garrick Wallstrom